We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The review of the safety of isotretinoin has concluded.
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
Check if you need to tell DVLA about a health or medical condition, how to report medical conditions to DVLA
Find out about coronavirus (COVID-19) treatments available outside of hospital, including information on free prescriptions and lateral flow tests.
This guidance provides information on comparator products used in studies supporting abridged marketing authorisation applications
An approach to payment for providers of IAPT services that links payment to patient outcomes as well as the provider’s levels of activity.
Volume 19 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
How to register your medical devices with the Medicines and Healthcare products Regulatory Agency (MHRA) for the markets in Great Britain and Northern Ireland
Information to support your recovery after COVID-19.
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
How to use an interrupted time series to evaluate your digital health product.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Foreign, Commonwealth & Development Office (FCDO) advice for lesbian, gay, bisexual and transgender (LGBT+) people travelling abroad.
The Brucella Reference Unit (BRU) provides laboratory diagnostic and clinical management services for Brucella species.
We have more than 10 years’ experience of successfully working with our customers to develop solutions across the radioactive waste lifecycle and provide access to the full range of treatment, logistics, and disposal techniques and technology in the UK, Europe,...
You can claim relief to pay no Customs Duty and VAT if you're importing therapeutic substances of human origin, blood-grouping or tissue-typing reagents, or related packaging, solvents and accessories.
A rapid evidence assessment and qualitative study that aims to improve understanding of the practice, experience and effect of conversion therapy.
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
Consultation on banning conversion therapy, and research reports on the nature, quality and quantity of evidence on its prevalence and practice.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.